Arena BioWorks
Kristine Daley is an experienced finance professional currently serving as Controller at Arena BioWorks since April 2024. Prior to this role, Kristine was the Sr. Director of Finance and Controller at Carbon Biosciences, where responsibilities included overseeing financial operations and compliance with the Sarbanes-Oxley Act. Kristine has held various pivotal positions, including Interim Controller at multiple organizations, Director of Client Controller at Monomoy Advisors, and Corporate Controller at AVROBIO, where contributions included leading successful IPOs and building accounting teams. Earlier career roles included significant responsibilities at Karyopharm Therapeutics Inc., Zalicus Incorporated, GlassHouse Technologies, and Coley Pharmaceutical Group, with a strong focus on general accounting, financial reporting, and regulatory compliance. Kristine holds a BSBA in Accounting from Suffolk University.
This person is not in any teams
Arena BioWorks
Arena BioWorks is a biomedical research institute focused on uncovering the mechanisms of human disease to identify opportunities for therapeutic intervention. The Institute's private funding model allows Arena to advance novel therapeutics by forming and supporting biotech companies up to early clinical / Series B stage. To learn more, visit arenabioworks.com.